Citadel Advisors »

Citius Oncology shares owned by Citadel Advisors

Quarter-by-quarter ownership of Citius Oncology (CTOR) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Citius Oncology

Tip: Access up to 7 years of quarterly data

All positions including Citius Oncology held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Oncology by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $36k 18k 2.03
2024-12-31 $26k 23k 1.15

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Citius Oncology

Armistice Capital
Vanguard Group
Geode Capital Management
XTX Topco
Renaissance Technologies
State Street Corporation
IFP Advisors
Northern Trust
Citadel Advisors
Tower Research Capital
Advisor Group Holdings
Arkadios Wealth Advisors
UBS Group
Farther Finance Advisors

View all funds holding Citius Oncology